Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine
- PMID: 7855231
- DOI: 10.1007/BF02245001
Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine
Abstract
Seroquel (ICI 204,636) is a mixed D2/5HT2 antagonist with a preclinical profile suggestive of potential antipsychotic efficacy. We compared seroquel to clozapine in an animal model of sensorimotor gating deficits in shizophrenic patients. Like schizophrenic patients, rats treated with apomophrine (APO) exhibit deficits in prepulse inhibition (PPI) of acoustic startle. The ability of antipsychotics to restore PPI in APO-treated rats correlates (Rs = 0.991) with their clinical potency. Seroquel and clozapine both restore PPI in APO-treated rats. Seroquel's restoration of PPI in apomorphine-treated rats follows simple monotonic ascending dose-response properties, and is not accompanied by consistent changes in startle reflex amplitude. Seroquel's profile in this PPI model mimics that of other antipsychotics.
Similar articles
-
Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.Psychopharmacology (Berl). 1998 Nov;140(1):75-80. doi: 10.1007/s002130050741. Psychopharmacology (Berl). 1998. PMID: 9862405
-
Seroquel restores sensorimotor gating in phencyclidine-treated rats.J Pharmacol Exp Ther. 1996 Dec;279(3):1290-9. J Pharmacol Exp Ther. 1996. PMID: 8968353
-
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.Pharmacol Biochem Behav. 1993 Mar;44(3):741-4. doi: 10.1016/0091-3057(93)90193-w. Pharmacol Biochem Behav. 1993. PMID: 8451276
-
Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.Arch Gen Psychiatry. 1994 Feb;51(2):139-54. doi: 10.1001/archpsyc.1994.03950020063007. Arch Gen Psychiatry. 1994. PMID: 8297213 Review.
-
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.Psychopharmacology (Berl). 2001 Jul;156(2-3):117-54. doi: 10.1007/s002130100811. Psychopharmacology (Berl). 2001. PMID: 11549216 Review.
Cited by
-
JL 13, an atypical antipsychotic: a preclinical review.CNS Drug Rev. 2003 Spring;9(1):41-56. doi: 10.1111/j.1527-3458.2003.tb00243.x. CNS Drug Rev. 2003. PMID: 12595911 Free PMC article. Review.
-
Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation.Psychoneuroendocrinology. 2019 Oct;108:53-61. doi: 10.1016/j.psyneuen.2019.06.009. Epub 2019 Jun 14. Psychoneuroendocrinology. 2019. PMID: 31228750 Free PMC article.
-
Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.CNS Drug Rev. 2003 Summer;9(2):159-86. doi: 10.1111/j.1527-3458.2003.tb00247.x. CNS Drug Rev. 2003. PMID: 12847557 Free PMC article. Review.
-
Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next.J Psychopharmacol. 2016 Nov;30(11):1072-1081. doi: 10.1177/0269881116661075. Epub 2016 Aug 18. J Psychopharmacol. 2016. PMID: 27539931 Free PMC article. Review.
-
Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.J Neurosci. 2000 Jun 1;20(11):4325-36. doi: 10.1523/JNEUROSCI.20-11-04325.2000. J Neurosci. 2000. PMID: 10818168 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
